Wearable Noise Is Exploding — Trust Is the Filter
The challenge is determining whether wearable data is reliable enough to relieve the review burden, guide care, support reimbursement, or reassure a patient who is worried about their heart rhythm…
Health
Trust, Technology and the Future of Interoperability: Solving Problems That Impact Real Lives
Healthcare interoperability isn’t an abstract concept; it’s about human connection, building trust and easing burden on patients and their care providers. The post Trust, Technology and the Future of Interoperability:…
STAT+: Pharmalittle: We’re reading about Medicare’s obesity drug pilot, an experimental Roche MS drug, and more
The Trump administration has dropped a plan for insurers to provide cheap weight loss drugs to seniors through a Medicare pilot program
Dayne Williams, Quantum Health
Quantum Health is one of the biggest and original navigation companies. Dayne Williams came out of retirement to take over as CEO after Zane Burke retired for personal reasons (to…
Alignment Health Plan CEO: Sometimes When MA Plan is Pulling Out, the Provider is to Blame
At the annual Medicarians conference in Las Vegas that draws brokers, agents, agency owners and field marketing organizations, among others, Dawn Maroney suggested that payers are not always the “bad…
STAT+: With successful trials, Roche takes its MS drug to regulators, but safety questions loom
The Swiss drugmaker Roche presented the latest data for its experimental multiple sclerosis drug, setting the stage for the company to seek approval.
STAT+: From Revolution Medicines, more strong data on KRAS drug and a glimpse of a ‘novel class’ beyond it
A company that is changing the outlook on pancreatic cancer has more promising data for treatments near-term and for a generation beyond.
STAT+: At AACR, more strong results for Revolution Medicine’s KRAS drug, plus assurance from NCI’s director
At AACR, Revolution Medicines presented more eye-catching data about its KRAS-targeting treatment, and Anthony Letai declared the state of cancer research steady.
STAT+: Key GOP senators push back on Trump’s plan to cut NIH, reorganize HHS
Lawmakers seem poised to reject cuts to biomedical research and public health spending for a second straight year.
STAT+: Trump’s plan to give seniors cheaper obesity drugs in Medicare hits a snag
Health insurers would likely face a financial strain by participating in the Medicare pilot.